Pharma Journalist - Page 799 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

SillaJen initiates Phase 1/2 Clinical Trial of pexastimogene devacirepvec

NJ Bariatric Center welomes new participants for Low BMI Weight Loss surgery Study

Aradigm sought CRL from FDA pertaining to NDA for Linhaliq treating NCFBE patients

Araclon Biotech partners with TFS International to advance AD vaccine ABvac40 into Phase II

CHMP elicits positive response for Chugai’s HEMLIBRA

IRIS appoints Chris Belmont as interim CEO, revamps leadership Team

Sterling Pharma Solutions surges visibility in Japan

Solid Form Solutions obtained by Avista Pharma Solutions

Theradex Oncology appointed CRO for Alligator Biosciences’s ATOR-1015 phase I study

REGENXBIO forays into Strategic Partnership with FUJIFILM Diosynth Biotechnologies